We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.
Rapamycin used to prevent organ rejection after transplants and in cancer treatment was found to have anti-ageing effect and potential to treat COVID-19 patients.
Researchers from the biological control research foundation, Insilico Medicine, Life Extension and other institutions announced the landmark research on identifying metformin and rapamycin natural analogue in the Journal of aging.